In this article, the relationship between the knowledge of competitors and the development of new products in the field of capital medical equipment has been investigated. In order to identify the criteria for measuri...In this article, the relationship between the knowledge of competitors and the development of new products in the field of capital medical equipment has been investigated. In order to identify the criteria for measuring competitors’ knowledge and developing new capital medical equipment products, marketing experts were interviewed and then a researcher-made questionnaire was compiled and distributed among the statistical sample of the research. Also, in order to achieve the goals of the research, a questionnaire among 100 members of the statistical community was selected, distributed and collected. To analyze the gathered data, the structural equation modeling (SEM) method was used in the SMART PLS 2 software to estimate the model and then the K-MEAN approach was used to cluster the capital medical equipment market based on the knowledge of actual and potential competitors. The results have shown that the knowledge of potential and actual competitors has a positive and significant effect on the development of new products in the capital medical equipment market. From the point of view of the knowledge of actual competitors, the market of “MRI”, “Ultrasound” and “SPECT” is grouped in the low knowledge cluster;“Pet MRI”, “CT Scan”, “Mammography”, “Radiography, Fluoroscopy and CRM”, “Pet CT”, “SPECT CT” and “Gamma Camera” markets are clustered in the medium knowledge. Finally, “Angiography” and “CBCT” markets are located in the knowledge cluster. From the perspective of knowledge of potential competitors, the market of “angiography”, “mammography”, “SPECT” and “SPECT CT” in the low knowledge cluster, “CT scan”, “radiography, fluoroscopy and CRM”, “pet CT”, “CBCT” markets in the medium knowledge cluster and “MRI”, “pet MRI”, “ultrasound” and “gamma camera” markets in the high knowledge cluster are located.展开更多
放射性药物作为一种安全有效的治疗方法正在被越来越多的用于不同类型肿瘤的治疗研究中,通常使用优先与癌细胞结合或通过生理机制积累的药物到达全身或局部病灶,之后通过发射射线对病灶进行辐照以达到杀死癌细胞的效果,此外这些核素能...放射性药物作为一种安全有效的治疗方法正在被越来越多的用于不同类型肿瘤的治疗研究中,通常使用优先与癌细胞结合或通过生理机制积累的药物到达全身或局部病灶,之后通过发射射线对病灶进行辐照以达到杀死癌细胞的效果,此外这些核素能发射可成像的光子,从而可以无创地观察治疗药物的生物分布。放射性核素偶联药物(radionuclide drug conjugates,RDC)结合了精准靶向和强效杀伤两方面的优势,用携带放射性核素有效载荷的特异性单克隆抗体靶向癌细胞,将能量集中释放在细胞直径几倍的范围内,杀死癌细胞的同时最大程度地限制对肿瘤细胞附近正常组织细胞的损害,疗效良好、不良反应小、能够延长患者生存期,对于晚期肿瘤治疗至关重要。展开更多
文摘In this article, the relationship between the knowledge of competitors and the development of new products in the field of capital medical equipment has been investigated. In order to identify the criteria for measuring competitors’ knowledge and developing new capital medical equipment products, marketing experts were interviewed and then a researcher-made questionnaire was compiled and distributed among the statistical sample of the research. Also, in order to achieve the goals of the research, a questionnaire among 100 members of the statistical community was selected, distributed and collected. To analyze the gathered data, the structural equation modeling (SEM) method was used in the SMART PLS 2 software to estimate the model and then the K-MEAN approach was used to cluster the capital medical equipment market based on the knowledge of actual and potential competitors. The results have shown that the knowledge of potential and actual competitors has a positive and significant effect on the development of new products in the capital medical equipment market. From the point of view of the knowledge of actual competitors, the market of “MRI”, “Ultrasound” and “SPECT” is grouped in the low knowledge cluster;“Pet MRI”, “CT Scan”, “Mammography”, “Radiography, Fluoroscopy and CRM”, “Pet CT”, “SPECT CT” and “Gamma Camera” markets are clustered in the medium knowledge. Finally, “Angiography” and “CBCT” markets are located in the knowledge cluster. From the perspective of knowledge of potential competitors, the market of “angiography”, “mammography”, “SPECT” and “SPECT CT” in the low knowledge cluster, “CT scan”, “radiography, fluoroscopy and CRM”, “pet CT”, “CBCT” markets in the medium knowledge cluster and “MRI”, “pet MRI”, “ultrasound” and “gamma camera” markets in the high knowledge cluster are located.
文摘放射性药物作为一种安全有效的治疗方法正在被越来越多的用于不同类型肿瘤的治疗研究中,通常使用优先与癌细胞结合或通过生理机制积累的药物到达全身或局部病灶,之后通过发射射线对病灶进行辐照以达到杀死癌细胞的效果,此外这些核素能发射可成像的光子,从而可以无创地观察治疗药物的生物分布。放射性核素偶联药物(radionuclide drug conjugates,RDC)结合了精准靶向和强效杀伤两方面的优势,用携带放射性核素有效载荷的特异性单克隆抗体靶向癌细胞,将能量集中释放在细胞直径几倍的范围内,杀死癌细胞的同时最大程度地限制对肿瘤细胞附近正常组织细胞的损害,疗效良好、不良反应小、能够延长患者生存期,对于晚期肿瘤治疗至关重要。